In Brief: Cooper/Aspect Vision
This article was originally published in The Gray Sheet
Executive Summary
Cooper/Aspect Vision: Cooper Companies to acquire privately held contact lens maker Aspect Vision Care under a non-binding letter of intent agreement announced Sept. 3. Southampton, England-based Aspect is anticipated to generate $45-50 mil. in revenues "in its first full year with CooperVision," Cooper's specialty contact lens business, Cooper says. Aspect, which markets its lenses primarily in the United Kingdom and other European countries, "would provide CooperVision with an ideal platform to launch our specialty lens product line into the European market," stated Thomas Bender, Cooper CEO and president of CooperVision. In addition, CooperVision, which markets its lenses "predominantly in North America...would be able to offer Aspect's full range of traditional and frequent replacement products to practitioners in selected market niches in our dominant territories," Bender said. Terms were not disclosed...
You may also be interested in...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.